logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Chan, Kin Fei Adrian
    Born in March 1974
    Individual (2 offsprings)
    Officer
    icon of calendar 2024-08-30 ~ now
    OF - Director → CIF 0
    Kin Fei Adrian Chan
    Born in March 1974
    Individual (2 offsprings)
    Person with significant control
    icon of calendar 2024-08-30 ~ now
    PE - Right to appoint or remove directorsCIF 0
  • 2
    icon of address3rd Floor, 1 Ashley Road, Altrincham, Cheshire, United Kingdom
    Active Corporate (7 parents, 2648 offsprings)
    Total Assets Less Current Liabilities (Company account)
    1 GBP2016-09-30
    Officer
    icon of calendar 2022-07-18 ~ now
    OF - Secretary → CIF 0
Ceased 1
  • Beadle, John
    Company Director born in October 1964
    Individual
    Officer
    icon of calendar 2022-07-18 ~ 2024-08-30
    OF - Director → CIF 0
    John Beadle
    Born in October 1964
    Individual
    Person with significant control
    icon of calendar 2022-07-18 ~ 2024-08-30
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

INNDURA THERAPEUTICS (UK) LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Debtors
20,672 GBP2024-12-31
0 GBP2023-12-31
Cash at bank and in hand
12,714 GBP2024-12-31
51,990 GBP2023-12-31
Current Assets
33,386 GBP2024-12-31
51,990 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-35,350 GBP2023-12-31
Net Current Assets/Liabilities
27,652 GBP2024-12-31
16,640 GBP2023-12-31
Equity
Called up share capital
1 GBP2024-12-31
1 GBP2023-12-31
Retained earnings (accumulated losses)
27,651 GBP2024-12-31
16,639 GBP2023-12-31
Equity
27,652 GBP2024-12-31
16,640 GBP2023-12-31
Average Number of Employees
12024-01-01 ~ 2024-12-31
12022-07-18 ~ 2023-12-31
Amounts Owed By Related Parties
20,672 GBP2024-12-31
Current
0 GBP2023-12-31
Trade Creditors/Trade Payables
Current
227 GBP2024-12-31
203 GBP2023-12-31
Amounts owed to group undertakings
Current
0 GBP2024-12-31
24,152 GBP2023-12-31
Corporation Tax Payable
Current
2,552 GBP2024-12-31
4,014 GBP2023-12-31
Other Taxation & Social Security Payable
Current
0 GBP2024-12-31
6,981 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
2,955 GBP2024-12-31
0 GBP2023-12-31
Par Value of Share
Class 1 ordinary share
1 GBP2024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2024-12-31
100 shares2023-12-31

  • INNDURA THERAPEUTICS (UK) LIMITED
    Info
    Registered number 14240690
    icon of address3rd Floor 1 Ashley Road, Altrincham, Cheshire WA14 2DT
    PRIVATE LIMITED COMPANY incorporated on 2022-07-18 (3 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-07-17
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.